# FDA Inspection 1202263 - Phillip C. Williamson, Ph.D. - April 06, 2023

Source: https://www.keypedia.com/records/fda_inspections/phillip-c-williamson-phd/12be2101-d15f-4666-9adc-9692d646900c
Source feed: FDA_Inspections

> FDA Inspection 1202263 for Phillip C. Williamson, Ph.D. on April 06, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1202263
- Company Name: Phillip C. Williamson, Ph.D.
- Inspection Date: 2023-04-06
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1222040 - 2023-10-20](https://www.keypedia.com/records/fda_inspections/phillip-c-williamson-phd/7245edb3-696f-4450-8d5a-ddd891bfe628)
- [FDA Inspection 1220685 - 2023-10-13](https://www.keypedia.com/records/fda_inspections/phillip-c-williamson-phd/c19c6820-001d-46ec-b189-0d0c81b74323)
- [FDA Inspection 1220695 - 2023-10-05](https://www.keypedia.com/records/fda_inspections/phillip-c-williamson-phd/ba6e05e3-57ae-4b9f-9823-4c1de42d6866)
- [FDA Inspection 996289 - 2016-12-05](https://www.keypedia.com/records/fda_inspections/phillip-c-williamson-phd/71d70742-dbe2-483e-960d-2e1d05c6116a)
- [FDA Inspection 927631 - 2015-05-27](https://www.keypedia.com/records/fda_inspections/phillip-c-williamson-phd/2b99a7d1-91fa-48ac-ab0e-5efffa8f1787)

Company: https://www.keypedia.com/companies/phillip-c-williamson-phd/b38993b1-96ec-4bff-b11c-8ac4fd0d6d2e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d